Exploring the Synergy of AI, Remote Monitoring, IoT, Energy Optimization, and Sustainable Materials in Clinical Research
Progression in disability as measured by increase in the Expanded Disability Status Scale (EDSS) is commonly used as outcome variable in clinical trials concerning multiple sclerosis (MS). In this study...
Learn MorePatients’ walking ability is critical for assessing the EDSS, the disability scale commonly used in MS clinical practice. Such assessment is usually based on patients’ estimates or on the measures the neurologists observe during periodic visits. quality of life (HRQOL) in MS.
Learn MoreCurrent clinical assessments of people with multiple sclerosis are episodic and may miss critical features of functional fluctuations between visits.
Learn MoreIn the past decade there have been significant advancements in computer technology that have reduced the hardware form factor as well as increased energy efficient computing. Using network protocols for near field communication such as Body Area Networks (BANs).
Learn MoreThis study evaluated the gait and balance performance of two clinically distinct groups of recently diagnosed and minimally impaired multiple sclerosis (MS) patients (Expanded Disability Status Scale range 0-2.5), compared to control subjects.
Learn MoreIt is not currently known whether gait and balance measures are responsive to deterioration of motor function in multiple sclerosis (MS) patients with low EDSS scores (≤3.0).
Learn MoreThe purpose of this study is to identify the objective physical activity (PA) measurement tools and outputs that are used within Multiple Sclerosis (MS) literature.
Learn MoreThere is increased interest in the application of smartphone applications and wearable motion sensors among multiple sclerosis (MS) patients.
Learn MoreDisability measures in multiple sclerosis (MS) rely heavily on ambulatory function, and current metrics fail to capture potentially important variability in walking behavior.
Learn MoreThe objective was to establish the extent to which physical functioning capacity and self-report measures are able to predict the habitual walking performance in ambulatory persons with multiple sclerosis.
Learn MoreMultiple sclerosis (MS) is a progressive neurological disorder affecting between 2 and 2.5 million people globally. Tests of mobility form part of clinical assessments of MS.
Learn MoreDisability measures in multiple sclerosis (MS) fail to capture potentially important variability in walking behavior. More sensitive and ecologically valid outcome measures are needed to advance MS research.
Learn MorePeople with multiple sclerosis (PwMS) often experience a decline in gait performance, which can compromise their independence and increase falls.
Learn MoreSubtle gait and balance dysfunction is a precursor to loss of mobility in multiple sclerosis (MS).
Learn More